Treeline Biosciences
Pre-clinicalA biotechnology company developing small molecule medicines targeting historically undruggable proteins in oncology and other therapeutic areas.
Founded
2021
Focus
Small Molecules
About
A biotechnology company developing small molecule medicines targeting historically undruggable proteins in oncology and other therapeutic areas.
Funding History
2Total raised: $500M
Series B$300MARCH Venture PartnersApr 15, 2023
Series A$200MARCH Venture PartnersSep 15, 2021
Company Info
TypePrivate
Founded2021
LocationWatertown, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile